Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Seagen Inc.

Seagen Inc. (SGEN) Stock Overview

Explore Seagen Inc.’s financial performance, market position, analyst ratings, and future outlook.

SGEN●NASDAQ
HealthcareBiotechnology
$228.74
$0.16(0.07%)
U.S. Market is Open · 14:16

Seagen Inc. (SGEN)

Meyka AI Score

Z

Key Financials

Market Cap43.2B
P/E Ratio-69.32
EPS (TTM)$-4.00
ROE-0.21%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$209.26

SGEN Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Seagen Inc. (NASDAQ: SGEN) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Seagen Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of SGEN on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $209.26 for the NASDAQ listing.

Key metrics behind Seagen Inc.'s NASDAQ-traded stock include a P/E ratio of -69.32 and a market capitalization of 43.2B. Combined with our AI analysis, these give both institutional and retail investors a clear view of SGEN on the NASDAQ.

Price Performance (NASDAQ: SGEN)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
-0.07%
3-Month Change
6.66%
6-Month Change
16.70%
Year-to-Date (YTD) Change
N/A
1-Year Change
73.24%
3-Year Change
26.82%
5-Year Change
225.19%
All-Time (Max) Change
2591.06%

Contact Information

https://www.pfizer.com
425 527 4000
21823 30th Drive SE, Bothell, WA, 98021

Company Facts

32,560 Employees
IPO DateMar 9, 2001
CountryUS

Frequently Asked Questions